🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Dhiigaa › New York › Buffalo

Qorannoo klinikaalii Dukkana Dhiigaa Buffalo, NY keessatti

Qorannoo 7 Dukkana Dhiigaa f Buffalo fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Roswell Park Cancer Institute, Buffalo
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04242095

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Namoota walitti qabaa jiraSadarkaa 3
  • Quetzal Site 4, Buffalo
Umuriin 18 hanga 71 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07504458

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • State University of New York at Buffalo, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Roswell Park Comprehensive Cancer Center, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Roswell Park Cancer Institute, Buffalo
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Roswell Park Comprehensive Cancer Center, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • Roswell Park Comprehensive Cancer Center, Buffalo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

Qorannoo Dukkana Dhiigaa magaalota biroo keessatti

Qorannoo biroo Buffalo keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.